John Thomas Pinto
Ph.D., (Biochemistry), University of Medicine and Dentistry of NJ, 1974
Selected Peer-Reviewed Publications (2006-2008)
Pinto JT, Krasnikov BF, and Cooper AL. Redox-sensitive proteins are potential targets of garlic-derived mercaptocysteine derivatives. J. Nutr, 136:835S-841S, 2006.
El-Bayoumy K, Sinha R, Pinto JT, and Rivlin RS. Cancer Chemoprevention by garlic and garlic-containing sulfur and selenium compounds. J. Nutr, 136:864S-869S, 2006.
Cooper AJL and Pinto, JT. Cysteine S-conjugate b-lyases. Amino Acids, 30:1-15, 2006.
Cho S, Szeto HH, Kim E., Kim
HJ, Tolhurst A, and Pinto JT.
A novel cell permeable antioxidant peptide, SS31, attenuates ischemic brain
injury by down-regulating CD36.
J Biol Chem. 282(7):4634-42. 2007.
Pinto JT, Sinha R, Papp K, Facompre ND, Desai D, and El-Bayoumy K. Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells. Int J Cancer. 120(7):1410-1417, 2007.
Sinha R, Pinto JT, Facompre N, Kilheffer J, Baatz JE, and El-Bayoumy K. Effects of naturally occurring and synthetic organoselenium compounds on protein profiling in androgen responsive and androgen independent human prostate cancer cells. In Press: Nutr Cancer, 2008.
Huang Z, Pinto JT, Deng H, and Richie JP, Jr. Inhibition of Caspase-3 Activity and Activation by Protein Glutathionylation. In Press: Biochem Pharm, 2008.
HBSV 5011: Advanced nutrition II
In-depth review of current knowledge and research on the biochemical and physiological aspects of vitamins, minerals, and phytonutrients; applications to diet.